chr6-167338772-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031949.5(TTLL2):c.173G>A(p.Arg58Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,613,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031949.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL2 | NM_031949.5 | c.173G>A | p.Arg58Gln | missense_variant | 2/3 | ENST00000239587.10 | NP_114155.4 | |
TTLL2 | NM_001410948.1 | c.-15-1333G>A | intron_variant | NP_001397877.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL2 | ENST00000239587.10 | c.173G>A | p.Arg58Gln | missense_variant | 2/3 | 1 | NM_031949.5 | ENSP00000239587.5 | ||
TTLL2 | ENST00000515138.1 | n.173G>A | non_coding_transcript_exon_variant | 2/6 | 1 | ENSP00000424130.1 | ||||
TTLL2 | ENST00000649884.1 | c.-15-1333G>A | intron_variant | ENSP00000497040.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152104Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248564Hom.: 0 AF XY: 0.0000521 AC XY: 7AN XY: 134418
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1460918Hom.: 0 Cov.: 30 AF XY: 0.0000509 AC XY: 37AN XY: 726732
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2024 | The c.173G>A (p.R58Q) alteration is located in exon 2 (coding exon 2) of the TTLL2 gene. This alteration results from a G to A substitution at nucleotide position 173, causing the arginine (R) at amino acid position 58 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at